Learn more

ADAMED SP Z OO

Overview
  • Total Patents
    14
About

ADAMED SP Z OO has a total of 14 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Poland. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and medical technology are SCHIAPPARELLI FARMA, ZENECA PHARMA SA and AMPHORA DISCOVERY CORP.

Patent filings in countries

World map showing ADAMED SP Z OOs patent filings in countries
# Country Total Patents
#1 Poland 14

Patent filings per year

Chart showing ADAMED SP Z OOs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Stawinski Tomasz 9
#2 Wieczorek Maciej 6
#3 Majka Zbigniew 5
#4 Sulikowski Daniel 3
#5 Matusiewicz Katarzyna Joanna 3
#6 Rusin Katarzyna Ewa 3
#7 Kowalczyk Piotr 3
#8 Kurowski Krzysztof 3
#9 Kludkiewicz Dominik Daniel 2
#10 Mirek Slawomir Wladyslaw 2

Latest patents

Publication Filing date Title
PL372356A1 New compounds, derivatives of 3-phenylpropionic acid
PL372332A1 New compounds, derivatives of 3-phenylpropionic acid
PL371841A1 New derivatives of 3-phenylpropionic acid
PL371307A1 Method for manufacture of n-demethylolanzapine
PL368213A1 New coupling, method for its fabrication and its application
PL355467A1 Pharmaceutical composition for filling hard gelatine capsules, method of producing pharmaceutical composition for filling hard gelatine capsules and hard the hard gelatine capsules
PL354642A1 Method of manufacture of alanzapine, new derivative of n-demethyl olanzapine and method of manufacture of new derivative of n-demethyl olanzapine
PL350717A1 Method of obtaining 4-amino 2-methyl-10h-thiene[2,3-b][1,5]benzodiazepine and method of obtaining olanzapine
PL347859A1 Method of obtaining crystalline azithromycin dihydrate
PL346517A1 Method of obtaining risedronic acid
PL341366A1 Method of obtaining amlodipin benzenesulphonate
PL326141A1 Intravaginal set and therapeutic method employing that set
PL325757A1 Method of obtaining amlopidine benzenosulphonate
PL319007A1 Method of obtaining 1-{[3-(5-nitro-2-furyl)-2-propenyliden]-amino}imidazolydin-2,4-dione